Appointment of Managing Director
Pfizer Ltd has informed BSE that the Board of Directors of the Company has appointed Mr. S. Sridhar as the Managing Director of the Company, with effect from March 18, 2016 for a period of 5 years. The appointment of Mr. S. Sridhar will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company. Interim Injunction on the prohibition of the manufacture and sale of "Corex"
Pfizer Ltd has informed BSE regarding "Interim Injunction on the prohibition of the manufacture and sale of "Corex"".
Pfizer stops selling popular Corex cough syrup in India after ban
Corex is a combination of chlopheniramine maleate and codeine syrupone of 344 drug combinations India banned over the weekend Prohibition on sale of drug "Chlopheniramine Maleate + Codeine Syrup"
Pfizer Ltd has informed BSE regarding Prohibition on sale of drug "Chlopheniramine Maleate + Codeine Syrup".
Doctors Without Borders opposes Pfizer's pneumonia vaccine patent in India
MSF is challenging this patent to ensure manufacturers planning to produce the pneumonia vaccine do not face patent barriers while launching more affordable versions Details of the meeting scheduled with Institutional Investor
Pfizer Ltd has informed BSE regarding "Details of the meeting scheduled with Institutional Investor". Pfizer launches Gelusil liquid in sachet format
Pharma major Pfizer's Global Established Products division on Thursday announced the launch of its largest selling antacid Gelusil liquid in and on the go sachet format in India. We have launched ... Pfizer to get patent for cholesterol lowering formulation
Global pharma giant Pfizer Inc has received a patent for invention to address the issues related to cholesterol and related disease including cardiovascular disease. The Indian Patent Office has said that the company amended its set of claims for ... Conference Call
Pfizer Ltd has submitted to BSE a copy of the transcript of the tele conference call with the analysts held on February 04, 2016, to discuss the Company's financial performance for the quarter ended December 31, 2015.The aforesaid information will be displayed on the website of the Company in compliance with Regulation 46 of the Listing Regulations. Updates
Pfizer Ltd has informed BSE that a teleconference call has been scheduled with the analysts on Thursday, February 04, 2016, at 3.30 p.m. to discuss the Company's financial performance for the quarter ended December 31, 2015.